1h Free Analyst Time
The publisher has been monitoring the artificial organs and bionic implants market in Spain and it is poised to grow by $456.53 mn during 2022-2026, progressing at a CAGR of 10.22% during the forecast period. The report on the artificial organs and bionic implants market in Spain provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The market is driven by the scarcity of organ donors and increase in the incidence of disabilities and organ failures.
The artificial organs and bionic implants market in Spain analysis includes product and end-user segments.
The artificial organs and bionic implants market in Spain is segmented as below:
By Product
- Artificial organs
- Bionic implants
By End-user
- Hospital and clinics
- Specialty centers
- Others
This study identifies technological advancements in the country as one of the prime reasons driving the artificial organs and bionic implants market growth in Spain during the next few years.
The report on artificial organs and bionic implants market in Spain covers the following areas:
- Artificial organs and bionic implants market sizing
- Artificial organs and bionic implants market forecast
- Artificial organs and bionic implants market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading artificial organs and bionic implants market vendors in Spain that include Abiomed Inc., Asahi Kasei Corp., Boston Scientific Corp., Edwards Lifesciences Corp., Medtronic Plc, Ossur hf., Ottobock SE and Co. KGaA, Sonova Holding AG, Terumo Medical Corp., and Zimmer Biomet Holdings Inc. Also, the artificial organs and bionic implants market in Spain analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021 - 2026
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Artificial organs - Market size and forecast 2021-2026
- Bionic implants - Market size and forecast 2021-2026
- Market opportunity by Product
Market Segmentation by End-user
- Market segments
- Comparison by End-user
- Hospital and clinics - Market size and forecast 2021-2026
- Specialty centers - Market size and forecast 2021-2026
- Others - Market size and forecast 2021-2026
- Market opportunity by End-user
Customer landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abiomed Inc.
- Asahi Kasei Corp.
- Boston Scientific Corp.
- Edwards Lifesciences Corp.
- Medtronic Plc
- Ossur hf.
- Ottobock SE and Co. KGaA
- Sonova Holding AG
- Terumo Medical Corp.
- Zimmer Biomet Holdings Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2021 - 2026 ($ million)
- Global market: Year-over-year growth 2021 - 2026 (%)
- Five forces analysis 2021 & 2026
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2021
- Product - Market share 2021-2026 (%)
- Comparison by Product
- Artificial organs - Market size and forecast 2021-2026 ($ million)
- Artificial organs - Year-over-year growth 2021-2026 (%)
- Bionic implants - Market size and forecast 2021-2026 ($ million)
- Bionic implants - Year-over-year growth 2021-2026 (%)
- Market opportunity by Product
- End-user - Market share 2021-2026 (%)
- Comparison by End-user
- Hospital and clinics - Market size and forecast 2021-2026 ($ million)
- Hospital and clinics - Year-over-year growth 2021-2026 (%)
- Specialty centers - Market size and forecast 2021-2026 ($ million)
- Specialty centers - Year-over-year growth 2021-2026 (%)
- Others - Market size and forecast 2021-2026 ($ million)
- Others - Year-over-year growth 2021-2026 (%)
- Market opportunity by End-user
- Customer landscape
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Abiomed Inc. - Overview
- Abiomed Inc. - Business segments
- Abiomed Inc. - Key offerings
- Abiomed Inc. - Key customers
- Abiomed Inc. - Segment focus
- Asahi Kasei Corp. - Overview
- Asahi Kasei Corp. - Business segments
- Asahi Kasei Corp. - Key offerings
- Asahi Kasei Corp. - Key customers
- Asahi Kasei Corp. - Segment focus
- Boston Scientific Corp. - Overview
- Boston Scientific Corp. - Business segments
- Boston Scientific Corp. - Key offerings
- Boston Scientific Corp. - Key customers
- Boston Scientific Corp. - Segment focus
- Edwards Lifesciences Corp. - Overview
- Edwards Lifesciences Corp. - Business segments
- Edwards Lifesciences Corp. - Key offerings
- Edwards Lifesciences Corp. - Key customers
- Edwards Lifesciences Corp. - Segment focus
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key offerings
- Medtronic Plc - Key customers
- Medtronic Plc - Segment focus
- Ossur hf. - Overview
- Ossur hf. - Business segments
- Ossur hf. - Key offerings
- Ossur hf. - Key customers
- Ossur hf. - Segment focus
- Ottobock SE and Co. KGaA - Overview
- Ottobock SE and Co. KGaA - Product and service
- Ottobock SE and Co. KGaA - Key offerings
- Ottobock SE and Co. KGaA - Key customers
- Ottobock SE and Co. KGaA - Segment focus
- Sonova Holding AG - Overview
- Sonova Holding AG - Business segments
- Sonova Holding AG - Key offerings
- Sonova Holding AG - Key customers
- Sonova Holding AG - Segment focus
- Terumo Medical Corp. - Overview
- Terumo Medical Corp. - Product and service
- Terumo Medical Corp. - Key offerings
- Terumo Medical Corp. - Key customers
- Terumo Medical Corp. - Segment focus
- Zimmer Biomet Holdings Inc. - Overview
- Zimmer Biomet Holdings Inc. - Business segments
- Zimmer Biomet Holdings Inc. - Key offerings
- Zimmer Biomet Holdings Inc. - Key customers
- Zimmer Biomet Holdings Inc. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the artificial organs and bionic implants market in Spain: Abiomed Inc., Asahi Kasei Corp., Boston Scientific Corp., Edwards Lifesciences Corp., Medtronic Plc, Ossur hf., Ottobock SE and Co. KGaA, Sonova Holding AG, Terumo Medical Corp., and Zimmer Biomet Holdings Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is technological advancements in the country.'
According to the report, one of the major drivers for this market is the scarcity of organ donors.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abiomed Inc.
- Asahi Kasei Corp.
- Boston Scientific Corp.
- Edwards Lifesciences Corp.
- Medtronic Plc
- Ossur hf.
- Ottobock SE and Co. KGaA
- Sonova Holding AG
- Terumo Medical Corp.
- Zimmer Biomet Holdings Inc.
